华润医药(03320.HK)：华润三九前三季度净利润约为28.99亿元 同比下降10.64%

Core Viewpoint - China Resources Pharmaceutical (03320.HK) reported a total revenue of approximately RMB 21.986 billion for the nine months ending September 30, 2025, reflecting a year-on-year increase of 11.38%. However, the net profit was approximately RMB 2.899 billion, showing a year-on-year decline of 10.64% [1]. Group 1 - The total revenue for the nine-month period reached approximately RMB 21.986 billion [1] - Year-on-year revenue growth was recorded at 11.38% [1] - The net profit for the same period was approximately RMB 2.899 billion [1] Group 2 - The net profit experienced a decline of 10.64% compared to the previous year [1]